FedQuery

Sigma-Aldrich, INC.

UEI WFYWL6SQ6FB8 · MO · subsidiary of Merck Kommanditgesellschaft Auf Aktien · SAM.gov record ↗

$-500K
FY2025 obligations
18
Contract awards
Nov 29, 2015
First action
Jun 15, 2026
Latest action

Monthly obligations

Oct 24
Nov 24
Feb 25
Mar 25
Apr 25
Jun 25
Jul 25
Aug 25
Sep 25
Dec 25
Jan 26
May 26
Jun 26

Contracts ending within 18 months (recompete watch)

PIIDDescriptionAgencyNAICSObligatedStartEnd
75F40125P00170REAGENTS AND CONSUMABLES FOR CONDUCTING MISSION-CRITICAL INTERDISCIPLINARY RESEARCHFood And Drug Administration541714$147KAug 11, 2025Aug 12, 2026
68HERF26P0088LABORATORY SUPPLIES (BULK ORDER) FOR CHEMICALS, MULTI-SPECIES HORMONE PANELS AND OTHER ITEMS. INVOICE APPROVERS: JOHN SOUTHERLAND (PRIMARY); ELIN ULRICH (ALTERNATE).Environmental Protection Agency424690$34KJun 7, 2026Aug 30, 2026
75N95025P00392NIDA LAB REQUIRES MILLI-Q IQ 7003 IN ORDER TO WATER PURIFICATION SYSTEM IS NEEDED FOR CELL CULTURE EXPERIMENTSNational Institutes Of Health541714$0Sep 8, 2025Sep 7, 2026
75D30126P21162HPCLS REAGENT ACQUISITIONCenters For Disease Control And Prevention325414$758Jun 21, 2026Sep 25, 2026
75N92B26P00008SIGMA MILLIPORE POTS #: 26-000371National Institutes Of Health339113$23KJan 15, 2026Jan 14, 2027
1333ND25PNB640056MANUFACTURING OF A MONOCLONAL ANTIBODY EXPRESSED FROM THE NISTCHO CELLNational Institute Of Standards And Technology541714$500KFeb 4, 2025Dec 9, 2027

Largest awards

PIIDDescriptionAgencyNAICSObligatedStartEnd
1333ND25PNB640056MANUFACTURING OF A MONOCLONAL ANTIBODY EXPRESSED FROM THE NISTCHO CELLNational Institute Of Standards And Technology541714$500KFeb 4, 2025Dec 9, 2027
75F40125P00170REAGENTS AND CONSUMABLES FOR CONDUCTING MISSION-CRITICAL INTERDISCIPLINARY RESEARCHFood And Drug Administration541714$147KAug 11, 2025Aug 12, 2026
68HERF26P0088LABORATORY SUPPLIES (BULK ORDER) FOR CHEMICALS, MULTI-SPECIES HORMONE PANELS AND OTHER ITEMS. INVOICE APPROVERS: JOHN SOUTHERLAND (PRIMARY); ELIN ULRICH (ALTERNATE).Environmental Protection Agency424690$34KJun 7, 2026Aug 30, 2026
75N92B26P00008SIGMA MILLIPORE POTS #: 26-000371National Institutes Of Health339113$23KJan 15, 2026Jan 14, 2027
75N92025P00083[25-007210] NIH NHLBI LABORATORY OF MOLECULAR PHYSIOLOGY REQUIRES FLAG RESIN IN ORDER TO FOR PROTEIN PURIFICATION.National Institutes Of Health325998$12KFeb 27, 2025Apr 27, 2025
75N98025F00002LABORATORY EQUIPMENT AND SUPPLIESNational Institutes Of Health325414$12KOct 16, 2024Oct 29, 2025
75N98025F00033LAB SUPPLIESNational Institutes Of Health325414$11KFeb 28, 2025Oct 30, 2025
75N96025F00016SIGMA-ALDRICH INC:1107546 [25-008922]National Institutes Of Health325414$11KSep 25, 2025Oct 30, 2025
68HE0P25P0021LAB SUPPLIES - PR-ORD-25-01585: 2526B1E028: LABORATORY CHEMICALS VIA SIGMA ALDRICH INC.Environmental Protection Agency325998$8KJun 17, 2025Jun 17, 2025
75D30126P21162HPCLS REAGENT ACQUISITIONCenters For Disease Control And Prevention325414$758Jun 21, 2026Sep 25, 2026
SPMYM125P1087N4215851639531Defense Logistics Agency325998$162Jul 16, 2025Jul 20, 2025
75N98025A00013O/M ITEMS ONLY: CHEMICALS, BIOLOGICAL MATERIALSNational Institutes Of Health325414$0Sep 30, 2024
HHSN263201600046BO/M ITEMS ONLY: CHEMICALS, BIOLOGICAL MATERIALS; PLASTIC WARE.National Institutes Of Health325414$0Nov 29, 2015
75N95025P00392NIDA LAB REQUIRES MILLI-Q IQ 7003 IN ORDER TO WATER PURIFICATION SYSTEM IS NEEDED FOR CELL CULTURE EXPERIMENTSNational Institutes Of Health541714$0Sep 8, 2025Sep 7, 2026
75N93020P01289LECTIN FROM GALANTHUS NIVALISNational Institutes Of Health325414$-5Sep 2, 2020Oct 2, 2020
75N98C20P00020CHEMICALS REQUIRED FOR EXPERIMENTS. THESE WILL COVER FOR THE END OF THE FISCAL YEAR AND WHEN THE NEW FY BEGINS.National Institutes Of Health325199$-780Sep 8, 2020Oct 23, 2024
75N95020P00580TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.National Institutes Of Health325414$-8KSep 8, 2020Oct 8, 2020
HT942524P0161RESEARCH DEVELOPMENT FOR DRUG MANUFACTURING OF PHASE 2 AND 3 ARMY LIPOSOME FORMULATION CONTAINING QS-21 UNDER CURRENT GOOD MANUFACTURING PRACTICESDefense Health Agency325411$-1.2MSep 19, 2024Mar 21, 2026